ALLURION TECHNOLOGIES, INC. (ALUR) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US02008G1022
ALLURION TECHNOLOGIES, INC. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 15.23 m USD |
| Gross profit | 9.57 m USD |
| Operating income | -30.16 m USD |
| EBIT | -28.68 m USD |
| Net income | -28.76 m USD |
| Diluted EPS – continuing operations | -3.81 USD |
Full history since 2020, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About ALLURION TECHNOLOGIES, INC.
Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior change program. The company is headquartered in Natick, Massachusetts.
More stocks
- ADVENT TECHNOLOGIES HOLDINGS, INC. (ADNH)
- Banzai International, Inc. (PARA)
- Smart Powerr Corp. (CREG)
- Profusa, Inc. (PFSA)
- PHOENIX MOTOR INC. (PEVM)
- HIGH WIRE NETWORKS, INC. (HWNI)
- Vivakor, Inc. (VIVK)
- STARGUIDE GROUP, INC. (STRG)
- Tenon Medical, Inc. (TNON)
- CYABRA, INC. (CYAB)
- AMERICAN REBEL HOLDINGS INC (AREB)
- MSP Recovery, Inc. (MSPR)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.